Evolent Health Price to Sales Ratio 2014-2025 | EVH
Historical PS ratio values for Evolent Health (EVH) over the last 10 years. The current P/S ratio for Evolent Health as of July 31, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Evolent Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-08-01 | 9.98 | 0.48 | |
| 2025-03-31 | 9.47 | $20.88 | 0.45 |
| 2024-12-31 | 11.25 | $22.29 | 0.50 |
| 2024-09-30 | 28.28 | $21.65 | 1.31 |
| 2024-06-30 | 19.12 | $20.80 | 0.92 |
| 2024-03-31 | 32.79 | $19.37 | 1.69 |
| 2023-12-31 | 33.03 | $17.73 | 1.86 |
| 2023-09-30 | 27.23 | $16.82 | 1.62 |
| 2023-06-30 | 30.30 | $15.82 | 1.92 |
| 2023-03-31 | 32.45 | $15.15 | 2.14 |
| 2022-12-31 | 28.08 | $14.50 | 1.94 |
| 2022-09-30 | 35.93 | $13.31 | 2.70 |
| 2022-06-30 | 30.71 | $12.35 | 2.49 |
| 2022-03-31 | 32.30 | $11.40 | 2.83 |
| 2021-12-31 | 27.67 | $10.62 | 2.61 |
| 2021-09-30 | 31.00 | $10.63 | 2.92 |
| 2021-06-30 | 21.12 | $10.85 | 1.95 |
| 2021-03-31 | 20.20 | $10.80 | 1.87 |
| 2020-12-31 | 16.03 | $10.87 | 1.47 |
| 2020-09-30 | 12.41 | $8.91 | 1.39 |
| 2020-06-30 | 7.12 | $8.72 | 0.82 |
| 2020-03-31 | 5.43 | $8.51 | 0.64 |
| 2019-12-31 | 9.05 | $8.39 | 1.08 |
| 2019-09-30 | 7.19 | $9.95 | 0.72 |
| 2019-06-30 | 7.95 | $9.24 | 0.86 |
| 2019-03-31 | 12.58 | $8.78 | 1.43 |
| 2018-12-31 | 19.95 | $8.14 | 2.45 |
| 2018-09-30 | 28.40 | $7.41 | 3.83 |
| 2018-06-30 | 21.05 | $7.02 | 3.00 |
| 2018-03-31 | 14.25 | $6.96 | 2.05 |
| 2017-12-31 | 12.30 | $7.12 | 1.73 |
| 2017-09-30 | 17.80 | $7.31 | 2.44 |
| 2017-06-30 | 25.35 | $7.17 | 3.54 |
| 2017-03-31 | 22.30 | $6.70 | 3.33 |
| 2016-12-31 | 14.80 | $5.85 | 2.53 |
| 2016-09-30 | 24.62 | $4.89 | 5.03 |
| 2016-06-30 | 19.20 | $4.47 | 4.29 |
| 2016-03-31 | 10.56 | $3.43 | 3.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.180B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.442B | 59.08 |
| Hims & Hers Health (HIMS) | United States | $14.813B | 153.91 |
| Doximity (DOCS) | United States | $11.035B | 51.09 |
| Tempus AI (TEM) | United States | $9.797B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.673B | 57.39 |
| Hinge Health (HNGE) | United States | $3.507B | 0.00 |
| Privia Health (PRVA) | United States | $2.380B | 162.67 |
| 10x Genomics (TXG) | United States | $1.656B | 0.00 |
| Phreesia (PHR) | United States | $1.604B | 0.00 |
| Enovis (ENOV) | United States | $1.531B | 8.53 |
| Azenta (AZTA) | United States | $1.497B | 69.57 |
| Schrodinger (SDGR) | United States | $1.492B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 27.44 |
| Claritev (CTEV) | United States | $0.655B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.505B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.423B | 0.00 |
| Talkspace (TALK) | United States | $0.407B | 121.50 |
| TruBridge (TBRG) | United States | $0.313B | 694.00 |
| Outset Medical (OM) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.179B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.074B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |